PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
A1AT 329 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.55
A1AT 329 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Anemia 81,663 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.52
A-Methapred (Methylprednisolone Sodium Succinate)- FDA 1 Drug Drug Adalimumab (Humira)- FDA 62 1 0.13 -0.70 1.00 0.82
744.1 22 Target Disease Cardiac Arrest 20,700 2 0.00 -0.95 0.09 0.62
744.1 22 Target Disease Heart Disease 118,291 2 0.00 -0.95 0.09 0.58
744.1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
744.1 22 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.98 0.05 0.64
744.1 22 Target Target Adiponectin 11,994 1 0.00 -0.98 0.05 0.62
744.1 22 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.05 0.61
744.1 22 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -0.98 0.05 0.60
744.1 22 Target Disease Liver Disease 49,817 1 0.00 -0.98 0.05 0.59
744.1 22 Target Disease Stroke 146,992 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Target Collagen 138,882 3 0.00 -0.91 0.17 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Target D(2) Dopamine Receptor 1,559 1 0.01 -0.97 0.06 0.68
5-Hydroxytryptamine 2b Receptor 18 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2a Receptor 67 Target Disease Pain 409,851 2 0.00 -0.98 0.03 0.54
5-Hydroxytryptamine 2a Receptor 67 Target Target Sphingomyelinase 3,060 1 0.00 -0.99 0.01 0.64
5-Hydroxytryptamine 2a Receptor 67 Target Disease Mania 7,698 1 0.00 -0.99 0.01 0.61
5-Hydroxytryptamine 2a Receptor 67 Target Target BDNF 11,163 1 0.00 -0.99 0.01 0.60
5-Hydroxytryptamine 2a Receptor 67 Target Disease Autism 20,962 1 0.00 -0.99 0.01 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Psoriasis 26,882 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Target EGF 27,487 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Disease Seizures 66,465 1 0.00 -0.99 0.01 0.56
5-Hydroxytryptamine 2a Receptor 67 Target Target Collagen 138,882 1 0.00 -0.99 0.01 0.55
5-Hydroxytryptamine 2a Receptor 67 Target Disease Inflammation 252,734 1 0.00 -0.99 0.01 0.53
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
4-Mercaptopyridine 96 Drug Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
4-Mercaptopyridine 96 Drug Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
4-Mercaptopyridine 96 Drug Drug Doxorubicin 28,033 1 0.00 -0.99 0.01 0.58
4-Mercaptopyridine 96 Drug Disease Cancer 1,053,491 1 0.00 -0.99 0.01 0.50
4-Mercaptobenzoic Acid 70 Drug Disease Hepatitis 163,842 2 0.00 -0.99 0.03 0.56
4-Mercaptobenzoic Acid 70 Drug Disease Malaria 56,215 1 0.00 -0.99 0.01 0.56
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
4-1BB Receptor 20 Target Disease Conjunctivitis 8,825 1 0.00 -0.97 0.05 0.63
4-1BB Receptor 20 Target Disease Lung Carcinoma 13,423 1 0.00 -0.97 0.05 0.62
4-1BB Receptor 20 Target Disease Influenza 67,933 1 0.00 -0.97 0.05 0.58
4-1BB Receptor 20 Target Disease Shock 134,031 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Tuberculosis 146,217 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-1BB Ligand 135 Target Target CD137 474 33 0.13 -0.84 0.24 0.84
4-1BB Ligand 135 Target Disease Leukemia 162,805 9 0.00 -0.97 0.07 0.58
4-1BB Ligand 135 Target Disease Inflammation 252,734 7 0.00 -0.97 0.05 0.56
4-1BB Ligand 135 Target Disease Influenza 67,933 6 0.00 -0.98 0.04 0.59
4-1BB Ligand 135 Target Disease Lung Carcinoma 13,423 3 0.00 -0.99 0.02 0.62
4-1BB Ligand 135 Target Disease Keratitis 10,599 2 0.00 -0.99 0.01 0.61
4-1BB Ligand 135 Target Target ERK1 18,374 2 0.00 -0.99 0.01 0.60
4-1BB Ligand 135 Target Target CD34 24,598 2 0.00 -0.99 0.01 0.59
4-1BB Ligand 135 Target Target BTK 1,263 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Target CCL3 1,427 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.01 0.60
4-1BB Ligand 135 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Leukemias 14,152 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
4-1BB Ligand 135 Target Disease Arthritis 128,324 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cancer 1,053,491 55 0.00 -0.87 0.24 0.57
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Breast Cancer 173,695 13 0.00 -0.97 0.06 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Carcinoma 433,099 11 0.00 -0.98 0.05 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ERK1 18,374 8 0.00 -0.98 0.03 0.63
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Prostate Cancer 71,064 6 0.00 -0.99 0.03 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target EGF 27,487 5 0.00 -0.99 0.02 0.60
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Shock 134,031 5 0.00 -0.99 0.02 0.56
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target BDNF 11,163 4 0.00 -0.99 0.02 0.62
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Lung Cancer 91,416 4 0.00 -0.99 0.02 0.56
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target Adiponectin 11,994 3 0.00 -0.99 0.01 0.61
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target Cox-2 21,583 3 0.00 -0.99 0.01 0.59
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Hyperglycemia 28,168 3 0.00 -0.99 0.01 0.59
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Inflammation 252,734 3 0.00 -0.99 0.01 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target Peroxisome Proliferator-Activated Receptor Delta 355 2 0.01 -0.99 0.01 0.71
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ASK1 762 2 0.00 -0.99 0.01 0.69
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Glioblastoma 17,933 2 0.00 -1.00 0.01 0.59